Skip to main content
. 2020 Sep 18;61(6):993–998. doi: 10.1093/jrr/rraa092

Table 3.

Dose–volume parameters of the organs at risk

FP hIMRTa h3DCRTa P  b P  c
Median (range)
Lung V20Gya (%) 4.7 (2.1–9.6) 4.0 (1.9–8.6) 5.7 (2.7–10.7) < 0.0001 0.53
Rib max (Gy)d 74.2 (22.3–82.0) 61.0 (21.6–78.5) 61.9 (27.6–65.6) 0.062 < 0.01
Skin max (Gy)d 19.0 (16.7–37.5) 16.5 (9.4–42.0) 20.1 (11.0–51.2) 0.26 0.72
Spinal cord max (Gy)e 9.1 (2.4–12.0) 8.1 (4.3–9.4) 10.3 (8.4–16.2) 0.041 1.0
Esophagus max (Gy)e 13.3(3.9–16.6) 8.6 (6.4–13.9) 15.3 (11.1–19.1) 0.022 1.0
Trachea max (Gy)e 16.7 (16.0–27.7) 14.1 (11.4–42.6) 25.5 (17.3–34.7) 0.091 1.0
Heart max (Gy)e 4.2 (0.4–43.6) 1.7 (0.3–44.0) 2.2 (0.4–61.0) 0.074 1.0
Great vessels
D10ml Max (Gy)a,e 21.8 (7.0–37.9) 17.5 (12.6–32.6) 25.9 (22.0–45.9) 0.022 1.0

ahIMRT = helical-IMRT mode, h3DCRT = helical-3DCRT mode, V20Gy = percentage volume receiving 20 Gy, D10ml = irradiated dose to 10 mL of the volume.

b P Value among three plans.

c P Value between FP and hIMRT plans.

dFor tumors located in peripheral zone (n = 9).

eFor tumors located in central zone (n = 5).